https://www.proteomics.com.au/news-media/proteomics-inks-five-year-extension-to-british-distribution-agreement-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/proteomics-international-pty-ltd-bloghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(7)-1.pngFrame13271Frame13271https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(6)-2.pngFrame13262Frame13262https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/s3.webps3s3https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/PromarkerEso/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEso2025-07-31https://www.proteomics.com.au/presentations/proteomics-international-presents-at-apac-symposia-serieshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/news-media/smallcaps-proteomics-predictive-diabetes-test-to-be-sold-in-us-and-could-soon-be-coming-to-australiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/new-diagnostic-blood-test-showcased-at-worlds-premier-endometriosis-conferencehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/newsletters/july-newsletter-2022https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-seals-exclusive-deal-for-kidney-test-in-us-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/publications/identification-of-plasma-protein-biomarkers-for-endometriosis-and-the-development-of-statistical-models-for-disease-diagnosishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/newsletters/october-newsletter-2020https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/physician-supporthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/s1.webps1s12025-11-04https://www.proteomics.com.au/news-media/proteomics-set-for-revenue-boost-after-launching-two-products2025-11-17https://www.proteomics.com.au/news-media/proteomics-nails-us-pricing-milestone-for-diabetes-test-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/biospectrum-asia-proteomics-launches-diagnostic-test-leader-promarkerdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/publications/peptide-analysis-of-mammalian-decomposition-fluid-in-relation-to-the-post-mortem-intervalhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-on-the-radiohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/us-update-promarkerd-licensing-negotiationshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/lorne-proteomics-conference-2011https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-15https://www.proteomics.com.au/news-media/proactive-investors-australia-proteomics-international-laboratories-boosts-balance-sheet-with-sale-of-cpr-pharma-services-stakehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-receives-1.7-million-in-rd-tax-incentivehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/presentations/investor-presentation-canary-capitalhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-world-first-blood-test-tracks-muscle-recovery-in-athletes-the-agehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/video-interview-exclusive-agreement-with-sonic-healthcare-usahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/new-clinical-advisory-board-to-support-promarkerd-global-rollout-yahoo-financehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/newsletters/january-newsletter-2023https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/driving-drug-and-diagnostic-development-in-renal-biomarkershttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/pipelinehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/download-logo.pngdownloadlogodownloadlogohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/PI%20Product%20Pipeline%20thumbnail.pngPIProductPipelinethumbnailPIProductPipelinethumbnailhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-11-26https://www.proteomics.com.au/publications/application-of-a-validated-prognostic-plasma-protein-biomarker-test-for-renal-decline-in-type-2-diabetes-to-type-1-diabetes-the-fremantle-diabetes-study-phase-iihttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/publications/proteome-mapping-of-human-skim-milk-proteins-in-term-and-preterm-milkhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/product-bloghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2096.pngFrame96Frame962025-08-28https://www.proteomics.com.au/news-media/clinical-study-boosts-proteomics-kidney-test-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/newsletters/spring-newsletter-2014https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-stress-test-stamped-with-european-patent-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/proteomics-boosts-kidney-test-prospects-with-board-gains-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-29https://www.proteomics.com.au/news-media/as-kidney-disease-reaches-critical-levels-doctors-urge-responsibility-6pr-perth-radiohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/diabetes-treatment-lowers-promarkerd-risk-score-results-to-be-presented-at-australasian-diabetes-conferencehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/presentations/promarkerd-a-predictive-test-for-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/news-media/1.1m-tax-rebate-booster-for-proteomics-coffers-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/presentations/corporate-presentation-australia-biotech-investhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/project-consultationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20166.pngFrame166Frame166https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Line%2014.pngLine14Line14https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-31https://www.proteomics.com.au/news-media/nhs-facing-impossible-challenge-to-care-for-kidney-disease-patients-kidney-research-uk-warns-itvhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/presentations/piq-market-updatehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/us-price-locked-in-for-proteomics-diabetes-test-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerD2025-09-29https://www.proteomics.com.au/presentations/proteomics-international-attends-trade-show-at-the-20th-annual-lorne-proteomics-conference-2014https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/news-media/strategic-alliance-and-investment-in-cpr-pharma-serviceshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/publications/united-states-patent-us007348152b2https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/the-australian-financial-review-promarkerd-australian-developed-blood-test-could-help-for-30-million-diabeticshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-international-seeks-fda-approval-for-promarkerdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/presentations/investor-webinar-and-qa-session-3rd-october-2023https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/dr-borehamss-crucible-proteomics-international-labs-biotech-dailyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/first-distribution-agreement-for-promarkerd-immunoassayhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/publications/proteomic-analysis-of-the-venom-of-heterometrus-longimanus-asian-black-scorpionhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12026-01-16https://www.proteomics.com.au/promarkereso-professor-jacques-bergmanhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284022.jpgFrame1171284022Frame1171284022https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEso2025-10-16https://www.proteomics.com.au/news-media/proactive-investor-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/clinical-assay-performance-validates-proteomics-kidney-test-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/new-tests-to-spot-endometriosis-early-and-stop-years-of-agon-daily-mail-ukhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/presentations/agm-presentation-2020https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/australian-financial-reviewhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/presentations/proteomics-international-celebrates-indias-70th-independence-dayhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/news-media/pilot-test-kit-takes-proteomics-step-closer-to-sales-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/acn-newswire-promarkerd-diagnostic-test-leader-officially-launchedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/swapping-a-scalpel-for-a-blood-test-for-endometriosis-sufferers-bloomberg-prognosishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/proteomics-gaining-strong-traction-in-analytical-serviceshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-13https://www.proteomics.com.au/publications/identification-of-novel-circulating-biomarkers-predicting-rapid-decline-in-renal-function-in-type-2-diabetes-the-fremantle-diabetes-study-phase-iihttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/biospacehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/promarkerd-showcased-at-easdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/newsletters/january-newsletter-2017https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-international-engages-leave-a-nest-as-agent-in-japanhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/publications/temporal-tracking-of-cysteine-34-oxidation-of-plasma-albumin-as-a-biomarker-of-muscle-damage-following-a-bout-of-eccentric-exercisehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/promising-health-news-promarkerendo-abc-perth-drivehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/biospace-proteomics-international-announces-strategic-alliance-and-investment-in-cpr-pharma-services-targeting-new-diagnostic-tests-and-improved-drug-developmenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/newsletters/analytical-and-clinical-performance-of-a-novel-immunoassay-based-test-system-to-predict-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/news-media/hospital-healthcare-managementhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/piq-investor-presentation-121-tech-investment-hong-konghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/investor-presentation-non-deal-roadshow-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-international-showcased-promarker-platform-at-hupo-2019https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/proteomics-international-attends-biologics-world-korea-2013https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/presentations/investor-presentation-to-the-emerging-asx-gems-conferencehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-2.16m-rd-rebate-fuels-breakthrough-blood-tests-the-sydney-morning-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/world-first-cancer-test-unveiled-in-brisbane-newsreelhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/news-media/potential-breakthrough-blood-test-able-to-detect-people-with-endometriosishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/finfeed-proteomics-awarded-vital-ce-mark-registration-for-promarkerdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/ce-mark-for-promarkerd-immunoassay-kithttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/piq-investor-presentation-121-tech-investment-hong-konghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/the-west-australian-proteomics-builds-global-patent-protection-for-kidney-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/biospectrum-asia-diabetic-kidney-disease-could-overwhelm-our-health-systemshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/proteomics-targets-gastro-causing-parasitehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/australian-researchers-make-breakthrough-in-endometriosis-detection-sky-news-australiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-international-raises-3m-in-heavily-oversubscribed-placementhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/promarkerd-at-asn-kidney-weekhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/proteomics-international-enters-industry-export-awards-hall-of-famehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-international-inks-deal-with-oxford-for-endometriosis-samples-360dxhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/promarkerd-advisory-boardhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Homepage-Video-1.mp4/medium.jpgHomepage-Video-1Homepage-Video-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Homepage-Video-1.mp431nonohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-1.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/clinical-studies%20(1).pngclinicalstudies1clinicalstudies1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-252%20(1).pngimage2521image2521https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/PromarkerD/Advisory%20Board/Merlin%20Thomas%201.pngMerlinThomas1MerlinThomas1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-23.pngimage23image23https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/team_banner-1%201.webpteambanner11teambanner11https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-2.pngimage2image2https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-343.pngFrame343Frame343https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image.pngimageimage2025-10-16https://www.proteomics.com.au/news-media/partnership-with-qimr-berghofer-targets-oesophageal-cancerhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/acn-newswire-proteomics-international-announces-strategic-alliance-and-investment-in-cpr-pharma-services-targeting-new-diagnostic-tests-and-improved-d-1754983867629https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/boost-for-proteomics-in-fight-against-painful-disorder-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/proteomics-secures-contracts-for-pharmacokinetic-analysishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/senior-staffhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%201%20(7).pngRectangle17Rectangle17https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%201%20(4).pngRectangle14Rectangle14https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%201%20(8).pngRectangle18Rectangle18https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2096.pngFrame96Frame96https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%201%20(2).pngRectangle12Rectangle12https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%201%20(3).pngRectangle13Rectangle13https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Corporate/Staff%20Headshots/296db9bc6f8a0bbc642aecdd4f281d52006106391bddb7f246e31f4004c2115b%20(1).webp296db9bc6f8a0bbc642aecdd4f281d52006106391bddb7f246e31f4004c2115b1296db9bc6f8a0bbc642aecdd4f281d52006106391bddb7f246e31f4004c2115b1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Kirsten%20Peters.pngKirstenPetersKirstenPetershttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%201%20(1).pngRectangle11Rectangle11https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%201%20(5).pngRectangle15Rectangle152026-01-25https://www.proteomics.com.au/publications/proteomics-in-action-opening-doorways-to-new-drugshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/promarkerd-patent-granted-in-indiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/bloomberg-promarkerd-diagnostic-test-leader-officially-launchedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-international-asxpiq-secures-licence-for-oesophageal-cancer-biomarkers-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/promarkerd-completes-pre-assessment-for-medicare-rebatehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/the-market-herald-proteomics-asxpiq-partners-up-with-qimr-berghofer-institutehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/proteomics-international-asxpiq-inks-exclusive-licence-agreement-to-bring-promarkerd-to-the-us-market-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/genome-web-proteomics-international-australian-organizations-launching-a4m-research-facilityhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/2nd-annual-biomarkers-in-diagnostics-therapeutics-conference-2012-singaporehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/newsletters/october-newsletter-2022https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/presentations/agm-chairmans-address-and-investor-presentationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/promarkerd-diabetic-kidney-disease-patent-granted-in-japanhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/6m-boost-to-drive-industrial-scale-proteomics-facility-in-wa-the-sydney-morning-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/publications/canagliflozin-attenuates-promarkerd-diabetic-kidney-disease-risk-prediction-scoreshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-develops-new-blood-test-for-esophageal-cancer-bioworldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-bolsters-endometriosis-product-with-dual-aussie-partnership-the-sydney-morning-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/news-media/translating-biomarker-discovery-into-a-diagnostic-test-for-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/australian-trade-and-investment-commission-perth-biotech-goes-global-with-pioneering-kidney-disease-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/shareholder-presentation-annual-general-meetinghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/news-media/us-patent-granted-for-predictive-and-diagnostic-test-for-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/clients-testimonialshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/a2_Rel1_Aus_FullCol_RGB-300x279.pnga2Rel1AusFullColRGB300x279a2Rel1AusFullColRGB300x279https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Line%2014.pngLine14Line14https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/CIPLA-logo.pngCIPLAlogoCIPLAlogohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-2.pngFrame2Frame2https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Unichem_logo.jpg.webpUnichemlogojpgUnichemlogojpghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/logobiosanapharma100114-300x225.pnglogobiosanapharma100114300x225logobiosanapharma100114300x2252025-10-31https://www.proteomics.com.au/news-media/proteomics-secures-major-analytical-services-contracthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/kidney-disease-could-become-public-health-emergency-without-more-funding-charity-warns-sky-newshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerD2025-09-29https://www.proteomics.com.au/promarkerd-healthcare-providerhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Video/PromarkerD/PROMARKER%20D%20AU%201280x720.mp4/medium.jpgPROMARKER D AU 1280x720PROMARKER D AU 1280x720https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Video/PromarkerD/PROMARKER%20D%20AU%201280x720.mp4194nonohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/identification-1.svgidentification1identification1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/utility_02-1.svgutility021utility021https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/heart-image-healthcare.webpheartimagehealthcareheartimagehealthcarehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Picture1.pngPicture1Picture1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/doctors.svgdoctorsdoctorshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare-providers-banner-scaled-1%201.webphealthcareprovidersbannerscaled11healthcareprovidersbannerscaled11https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/monitring-1.svgmonitring1monitring1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/treatment-1.svgtreatment1treatment1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/utility_01-1.svgutility011utility0112025-12-01https://www.proteomics.com.au/news-media/proteomics-international-to-collaborate-on-world-first-blood-test-for-endometriosis-the-sentimenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/proteomics-internationalhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/frame-68-6821ddeec961b.webpframe686821ddeec961bframe686821ddeec961bhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/frame-39-6821dad76829d.webpframe396821dad76829dframe396821dad76829dhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/logo.pnglogologohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2055.pngFrame55Frame55https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Line%2014%20(1).pngLine141Line141https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Line%2014.pngLine14Line14https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2038.pngFrame38Frame38https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2017.pngFrame17Frame17https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-6821cf7b8f391.webpimage6821cf7b8f391image6821cf7b8f391https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20(1).pngFrame1Frame1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/frame-306-6821dcdc4ae19.webpframe3066821dcdc4ae19frame3066821dcdc4ae19https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-1-6821d2413cfcd.webpimage16821d2413cfcdimage16821d2413cfcdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame.pngFrameFrame2025-05-29https://www.proteomics.com.au/news-media/360dx-proteomics-international-nabs-ce-mark-for-kidney-disease-immunoassay-kithttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/proteomics-international-supports-fundraising-efforts-for-cancer-research-by-riding-in-the-sunsuper-ridehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/promarkerd-presented-at-australasian-proteomics-conferencehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/biomarker-discovery-and-validationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20160%20(1).pngFrame1601Frame1601https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/undefined-Sep-19-2025-10-27-45-3764-AM.pngundefinedSep1920251027453764AMundefinedSep1920251027453764AMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Targeted%20MS-1.pngTargetedMS1TargetedMS12026-01-16https://www.proteomics.com.au/terms-conditionshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Line%2014.pngLine14Line14https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20164.pngFrame164Frame1642025-11-13https://www.proteomics.com.au/news-media/cpt-pla-reimbursement-code-approved-in-us-for-promarkerdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/diabetes-test-receives-national-recognition-uwa-newshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/presentations/promarkerd-at-amcp-nexushttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/biosimilars/biologics-drug-characterisationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20161.pngFrame161Frame161https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/news-media/early-detection-for-oesophageal-cancer-medical-forumhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-on-fast-track-to-deliver-simple-endometriosis-blood-test-the-agehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/investor-insight-proteomics-internationals-predictive-test-for-diabetic-kidney-disease-successfully-validated-in-major-clinical-studyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/promarkerd-showcased-at-american-diabetes-association-conference-2019https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/newslettershttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2096.pngFrame96Frame962025-08-15https://www.proteomics.com.au/publications/detecting-changes-in-the-thiol-redox-state-of-proteins-following-a-decrease-in-oxygen-concentration-using-a-dual-labeling-techniquehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/presentations/proteomics-international-india-trade-visit-24th-28th-september-2018https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-international-laboratories-set-to-expand-its-commercial-footprint-in-the-us-video-proactive-investorshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/presentations/promarkerd-showcased-at-easdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/publications/us-patent-methods-of-assessing-diabetic-nephropathy-using-cd5-antigen-likehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/protoemics-diabetes-test-gets-important-us-health-insurance-nod-brisbane-timeshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-07-31https://www.proteomics.com.au/promarkerhub-loginhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/undefined-Oct-08-2025-11-30-11-0217-AM.pngundefinedOct0820251130110217AMundefinedOct0820251130110217AMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(12).pngFrame13212Frame13212https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(11).pngFrame13211Frame13211https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(13).pngFrame13213Frame13213https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Line%2014%20(1).pngLine141Line141https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20344.pngFrame344Frame3442025-10-24https://www.proteomics.com.au/news-media/acn-newswire-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/genomeweb-proteomics-international-to-test-kidney-disease-test-as-cdx-for-investigational-treatmenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/proteomics-international-extends-global-leadership-in-precision-diagnostics-with-expanded-laboratory-in-perthhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Corporate/VIP%20Lab%20launch/IMG_9239_crop_square.jpgIMG9239cropsquareIMG9239cropsquarehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Corporate/VIP%20Lab%20launch/VIP%20Lab%20launch%20minister_and_John.jpgVIPLablaunchministerandJohnVIPLablaunchministerandJohnhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Corporate/VIP%20Lab%20launch/VIP%20lab%20launch%20Jason.jpgVIPlablaunchJasonVIPlablaunchJasonhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Corporate/VIP%20Lab%20launch/Signage-square-crop-edit.jpgSignagesquarecropeditSignagesquarecropedithttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Corporate/VIP%20Lab%20launch/VIP%20Lab%20launch%20VIP%20event.jpgVIPLablaunchVIPeventVIPLablaunchVIPeventhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Corporate/VIP%20Lab%20launch/VIP%20lab%20launch%20-ribbon%20cut.jpgVIPlablaunchribboncutVIPlablaunchribboncut2025-12-05https://www.proteomics.com.au/presentations/promarkerd-at-virtual-isporhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/science-and-the-stables-australian-startups-to-improve-equine-health-and-vet-practice-agrifutureshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-07-31https://www.proteomics.com.au/newsletters/july-newsletter-2020https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-international-planning-australia-launch-of-endometriosis-test-in-q2-us-launch-to-follow-360dxhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/cco-and-cfo-appointed-to-bolster-executive-teamhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/promarkerd-professor-ele-ferranninihttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image.pngimageimage2025-09-18https://www.proteomics.com.au/publications/from-nanoflow-to-standard-flow-lc/ms-for-routine-quantitative-plasma-proteomics-in-diabetic-kidney-disease-researchhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/presentations/proteomics-international-attends-trade-shows-at-the-arab-health-2014-diabetes-conference-in-dubaihttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/news-media/proteomics-international-contracts-biotem-to-manufacture-promarkerd-test-kitshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/big-pharma-clinical-study-validates-promarkerd-kidney-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/clinical-validation-study-confirms-promarkerdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-engages-abcam-to-manufacture-promarkerd-reagentshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/investor-relationshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/234%20Proteomics.webp234Proteomics234Proteomicshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-21https://www.proteomics.com.au/news-media/the-west-australian-biotech-on-the-global-maphttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/health-check-the-endo-metriosis-proteomics-is-on-the-case-the-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/proteomics-and-bioinformatics-conference-2011-hyderabad-indiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-15https://www.proteomics.com.au/promarkereso-professor-krish-ragunathhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEsohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284027.jpgFrame1171284027Frame1171284027https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-10-16https://www.proteomics.com.au/news-media/proteomics-international-laboratories-asxpiq-receives-1.1m-rd-tax-refund-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/newsletters/july-newsletter-2019https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/presentations/proteomics-international-india-road-trip-2013https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/news-media/blood-test-or-crystal-ball-looking-into-the-future-of-our-health-the-sentiment-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/proteomics-technical-presentationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/360dx-proteomics-international-laboratories-transfers-diabetic-kidney-disease-test-tech-to-atturoshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/the-market-herald-proteomics-international-asxpiq-receives-covid-19-research-grantshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/bio-2010-chicago-usahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-09https://www.proteomics.com.au/proteomics-international-asxpiq-inks-exclusive-licence-agreement-to-bring-promarkerd-to-the-us-market-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-29https://www.proteomics.com.au/news-media/video-proteomics-international-laboratories-ltd-asxpiq-interview-with-managing-director-dr.-richard-lipscombehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-11-19https://www.proteomics.com.au/news-media/supplementary-prospectus-issuedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/proteomics-international-awarded-100000-manufacturing-fundinghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/the-market-herald-proteomics-receives-ce-mark-for-kidney-disease-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/promarkerd-individualshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/patient01.svgpatient01patient01https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/imgi_19_patient_banner-1%201.webpimgi19patientbanner11imgi19patientbanner11https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/plan_treatment.svgplantreatmentplantreatmenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Vector.svgVectorVectorhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/patients-early-detection-1.jpgpatientsearlydetection1patientsearlydetection1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2026-03-17https://www.proteomics.com.au/specialist-protein-testinghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20165.pngFrame165Frame165https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12026-01-16https://www.proteomics.com.au/publications/the-new-and-the-old-platform-cross-validation-of-immunoaffinity-mass-spectrometry-versus-elisa-for-promarkerd-a-predictive-test-for-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proactive-investors-australia-proteomics-international-to-present-at-diabetes-conference-featuring-promarkerd-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/medical-big-guns-help-proteomics-rev-up-aussie-cancer-test-rollout-the-sydney-morning-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-09https://www.proteomics.com.au/presentations/promarkerd-at-the-american-diabetes-associations-81st-scientific-sessionshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/an-overview-of-proteomics-international-and-the-companys-technologyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/news-media/promarkerd-secures-tga-approval-for-software-ivd-and-indonesian-patenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/proteomics-strikes-kidney-disease-test-deal-in-italy-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/proteomics-banks-4.5m-to-fast-track-novel-diagnostic-test-launches-the-sydney-morning-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/milestone-first-patent-for-proteomics-simple-endometriosis-test-the-agehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/proteomics-receives-834k-in-rd-tax-incentivehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/publications/temporal-changes-in-thiol-oxidized-plasma-albumin-are-associated-with-recovery-from-exercise-induced-muscle-damage-after-a-marathonhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/newsletters/october-newsletter-2018https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/learning-from-uks-kidney-disease-crisis-medical-forum-magazinehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerD2025-09-29https://www.proteomics.com.au/news-media/the-west-australian-proteomics-to-develop-rapid-test-for-covid-19https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/proteomics-nears-agreement-to-sell-kidney-disease-test-in-usa-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/promarkereso-professor-hugh-barrhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEsohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284021-1024x536.jpgFrame11712840211024x536Frame11712840211024x5362025-10-16https://www.proteomics.com.au/presentations/proteomics-international-at-lorne-proteomics-2021https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/the-australian-australian-developed-blood-test-could-help-30-million-american-diabeticshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/sunday-times-kidney-test-winhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/newsletters/january-newsletter-2022https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/promarkerd-dr-andrew-frankelhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-343.pngFrame343Frame3432025-09-18https://www.proteomics.com.au/news-media/ce-mark-for-promarkerd-hub-predictive-software-for-dkdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/piq-investor-presentation-9th-june-2020https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-international-files-us-fda-513g-regulatory-submissionhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/newsletters/mouse-models-of-dominant-acta1-disease-recapitulate-human-disease-and-provide-insight-into-therapieshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-international-achieves-iso-13485-certificationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/newsletters/april-newsletter-2021https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/the-market-herald-proteomic-asxpiq-gets-ce-mark-for-promarkerd-immunoassay-kithttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/product-blog/product-blog-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-25https://www.proteomics.com.au/presentationshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2096.pngFrame96Frame96https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/news-media/proteomics-awards-inaugural-stem-scholarship-to-perth-teenagerhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/uk-nice-publishes-medtech-innovation-briefing-on-promarkerdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/reflux-to-result-proteomics-non-invasive-cancer-test-listcorphttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/proteomics-inks-five-year-extension-to-british-distribution-agreement-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerD2025-09-29https://www.proteomics.com.au/promarkerd-dr-alexander-turchinhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-4.pngimage4image42025-09-18https://www.proteomics.com.au/news-media/study-results-emerge-for-proteomics-international-laboratories-latest-cancer-diagnostic-test-the-sentimenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/wa-company-takes-further-step-towards-blood-test-for-endometriosishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/proteomics-gets-green-light-to-continue-diagnostic-mission-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-29https://www.proteomics.com.au/new-kidney-research-uk-report-shows-kidney-disease-is-a-public-health-emergencyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-29https://www.proteomics.com.au/newsletters/january-newsletter-2019https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/promarkerd-significantly-outperforms-current-standard-of-care-tests-in-predicting-future-kidney-function-decline-market-watchhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/new-proteomics-us-testing-lab-opens-door-to-vast-diagnostic-market-the-sydney-morning-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/promarkerd-latest-results-published-in-peer-reviewed-journalhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/proteomics-nails-us-pricing-milestone-for-diabetes-test-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-29https://www.proteomics.com.au/presentations/investor-presentation-euroz-hartleys-healthcare-forumhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/lorne-proteomics-conference-2011-ab-workshophttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-15https://www.proteomics.com.au/news-media/promarkerd-clinical-assay-performance-results-publishedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/initiation-of-coverage-by-independent-investment-researchhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/newsletters/january-newsletter-2021https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-international-develops-non-invasive-blood-based-diagnostic-for-endometriosis-clarivate-bioworldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/promarkerd-intellectual-property-portfolio-expandshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/proteomics-engages-growth-medics-to-expand-promarkerd-test-reach-in-eu-medical-device-networkhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/presentations/promarkerd-presented-by-american-diabetes-association-tvhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-launches-predictive-kidney-disease-test-in-australia-the-sydney-morning-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/new-oesophageal-cancer-diagnostic-shows-strong-performancehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/promarkereso-publicationshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/clinical_studies-1.webpclinicalstudies1clinicalstudies1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Screenshot%202025-10-14%20at%205.16.14%20PM.pngScreenshot20251014at51614PMScreenshot20251014at51614PMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/clinical-studies%20(1).pngclinicalstudies1clinicalstudies1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEsohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Screenshot%202025-10-14%20at%205.30.01%20PM.pngScreenshot20251014at53001PMScreenshot20251014at53001PMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/pdf.svgpdfpdfhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-252%20(1).pngimage2521image2521https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Untitled%20design.pngUntitleddesignUntitleddesignhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-10-16https://www.proteomics.com.au/presentations/lorne-proteomics-conference-2011https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/publications/reverse-phase-hplc-method-for-detection-and-quantification-of-lupin-seed-%CE%B3-conglutinhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-international-inks-deal-with-eurobio-scientific-for-french-distribution-of-kidney-test-360dxhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/business-news-proteomics-achieves-clinical-validation-for-kidney-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/the-blood-test-breakthrough-for-endometriosis-pain-7newshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/presentations/proteomics-international-attends-trade-show-and-presents-at-the-21st-annual-lorne-proteomics-symposiumhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/news-media/acn-newswirehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/promarkerd-us-market-updatehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/proteomics-on-bulls-bears-brokershttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/publications/method-for-determining-the-redox-status-of-proteinshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/world-leading-laboratory-launches-clinical-trials-testinghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/promarkerd-launched-in-spainhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/worlds-first-blood-test-for-endometriosis-step-closer-following-trial-success-science-alerthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/cancer-test-boosts-market-hopes-for-proteomics-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/perth-trial-proves-worth-of-proteomics-diabetes-related-blood-test-the-agehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/proteomics-nears-launch-of-groundbreaking-muscle-stress-test-brisbane-timeshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-09https://www.proteomics.com.auhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/AdobeStock_477276377.webpAdobeStock477276377AdobeStock477276377https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/20250930MC%20Promotion%20Banner2%20(1).png20250930MCPromotionBanner2120250930MCPromotionBanner21https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/20250930MC%20Banner%208.png20250930MCBanner820250930MCBanner8https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2028%20(7).webpFrame287Frame287https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20338.webpFrame338Frame338https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20344.pngFrame344Frame344https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(14).pngFrame13214Frame13214https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/frame-306-6821dcdc4ae19.webpframe3066821dcdc4ae19frame3066821dcdc4ae19https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(13).pngFrame13213Frame13213https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/banner%204.pngbanner4banner4https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/VscArrowSmallRight.pngVscArrowSmallRightVscArrowSmallRighthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/20250930MC%20Promotion%20Banner4.png20250930MCPromotionBanner420250930MCPromotionBanner4https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/20250930MC%20Promotion%20Banner1.png20250930MCPromotionBanner120250930MCPromotionBanner1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(12).pngFrame13212Frame13212https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/20250930MC%20Promotion%20Banner3.png20250930MCPromotionBanner320250930MCPromotionBanner3https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Line%2014%20(1).pngLine141Line141https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Corporate/VIP%20Lab%20launch/20251201SG%20VIP%20Lab%20Opening%20Aus_hero_approved-by-PP-4.jpg20251201SGVIPLabOpeningAusheroapprovedbyPP420251201SGVIPLabOpeningAusheroapprovedbyPP42026-03-29https://www.proteomics.com.au/presentations/international-study-validates-promarkerd-predictive-test-for-diabetic-kidney-disease-investor-teleconferencehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-on-a-game-changing-path-to-address-kidney-disease-ausbizhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/indian-ip-win-gives-proteomics-massive-global-cover-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/publications/proteomics-international-quarterly-activities-report-december-2025https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12026-01-30https://www.proteomics.com.au/news-media/proteomics-international-raises-8m-in-highly-successful-placementhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/presentations/proteomics-international-india-trade-visit-8th-12th-may-2017https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/promarkereso-professor-andrew-c.-changhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284023.jpgFrame1171284023Frame1171284023https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEso2025-10-16https://www.proteomics.com.au/news-media/business-news-asia-proteomics-international-announces-strategic-alliance-and-investment-in-cpr-pharma-serviceshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-pursues-predictive-test-for-diabetic-kidney-disease-in-asiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/productshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/HiOutlineArrowRight.pngHiOutlineArrowRightHiOutlineArrowRighthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(4)-1.pngFrame13241Frame13241https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(7)-1.pngFrame13271Frame13271https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/PI%20Product%20Pipeline%20thumbnail.pngPIProductPipelinethumbnailPIProductPipelinethumbnailhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Corporate/Promarker%20Hub%20760x458.pngPromarkerHub760x458PromarkerHub760x458https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(8)-1.pngFrame13281Frame13281https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20132%20(6)-2.pngFrame13262Frame132622025-10-29https://www.proteomics.com.au/news-media/business-news-proteomics-to-develop-rapid-test-for-covid-19https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/proteomics-international-receives-fy16-rd-tax-incentivehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-13https://www.proteomics.com.au/publications/quantitative-proteomic-analysis-of-g-protein-signalling-in-stagonospora-nodorum-using-isobaric-tags-for-relative-and-absolute-quantification-itraqhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/conversion-of-90-of-proteomics-options-raises-of-3mhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/oxidx-launched-to-maximise-oxidative-stress-technologyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/the-west-australian-proteomics-achieves-clinical-validation-for-kidney-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/publications/promarkerd-predicts-renal-function-decline-in-type-2-diabetes-in-the-canagliflozin-cardiovascular-assessment-study-canvashttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/us-price-locked-in-for-proteomics-diabetes-test-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/presentations/proteomics-internationals-india-visit-for-trade-and-conference-12th-18th-december-2016https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/news-media/study-shows-promarkerd-ability-to-also-predict-late-stage-kidney-decline-in-type-2-diabetes-patientshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/presentations/dr-amy-mottl-on-promarkerdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/the-west-australian-proteomics-jv-developing-blood-test-for-oesophageal-cancerhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/promarkerd-update-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-13https://www.proteomics.com.au/news-media/proteomics-enters-lucrative-uk-market-for-kidney-test-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/individualshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-48095811.svgFrame48095811Frame48095811https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/plan_treatment.svgplantreatmentplantreatmenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEsohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/syringe-svgrepo-com-1.svgsyringesvgrepocom1syringesvgrepocom1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/imgi_19_patient_banner-1%201.webpimgi19patientbanner11imgi19patientbanner11https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/iStock-1829570009-scaled-1.webpiStock1829570009scaled1iStock1829570009scaled12026-03-17https://www.proteomics.com.au/news-media/proteomics-international-u-of-melbourne-rwh-ink-deal-for-endometriosis-test-development-360dxhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/news-media/genomeweb-proteomics-international-investing-in-cpr-pharma-serviceshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/newsletters/may-newsletter-2025https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-15https://www.proteomics.com.au/news-media/ce-mark-for-predictive-test-for-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/promarkerd-at-amcp-virtualhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-takes-forward-step-with-blood-test-diagnosis-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/wa-business-news-proteomics-kit-fit-for-markethttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/heartbreaking-impact-of-endometriosis-on-women-laid-bare-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-signs-promarkerd-agreement-with-us-big-pharma-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/kidney-disease-could-become-public-health-emergency-without-more-funding-charity-warns-sky-newshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/presentations/promarkerd-showcased-at-american-diabetes-association-conference-2019https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/proteomics-international-india-trade-visit-19th-23rd-feb-2018https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/new-noninvasive-endometriosis-tests-are-on-the-rise2025-11-17https://www.proteomics.com.au/news-media/january-newsletter-2022https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-on-skybusinesshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/dr-michael-shanik-on-promarkerdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/novel-biomarkers-identified-for-asthma-and-copdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/it-takes-women-seven-years-to-be-diagnosed-with-endometriosis.-that-could-soon-change-9-newshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/promarkerd-professor-tim-davishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-23.pngimage23image232025-09-18https://www.proteomics.com.au/publications/the-second-coming-of-proteomics.-australian-biotechnologyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/list-of-serviceshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-13https://www.proteomics.com.au/news-media/sys.con-media-proteomics-international-announces-strategic-alliance-and-investment-in-cpr-pharma-serviceshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-2.2m-rd-rebate-to-fuel-diagnostics-test-rollouthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-11-20https://www.proteomics.com.au/news-media/proteomics-to-collaborate-to-validate-test-for-endometriosishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/the-posthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/presentations/proteomics-international-enters-industry-export-awards-hall-of-fame-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/new-blood-test-for-endometriosis-offers-improved-early-screeninghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/presentations/promarkerd-at-the-australasian-diabetes-congresshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/publications/protein-biomarker-research-pipeline-for-developing-protein-biomarkers-for-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-international-successfully-closes-ipohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/6pr-audio-hows-this-a-blood-test-that-can-predict-you-have-diabetic-kidney-disease-4-years-before-you-get-ithttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/frost-sullivan-promarkerd-diagnostic-test-world-leadinghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/promarkerd-predicting-diabetic-kidney-disease-before-symptoms-arrive-medical-forum-magazinehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/presentations/agm-chairmans-address-and-investor-presentation-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/managing-director-dr-richard-lipscombe-presents-at-the-australasian-life-science-and-healthcare-showcase-2015-in-seoulhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/publications/ramping-up-the-growth-of-proteomics-advancements-in-instrumentation-computing-power-and-drug-discovery-techniques-are-fuelling-the-growth-of-proteomicshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/4th-international-congress-on-prediabetes-the-metabolic-syndrome-2011-madrid-spainhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-15https://www.proteomics.com.au/news-media/proteomics-internationals-technical-expertise-and-accreditationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/global-head-of-business-development-appointedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/proteomics-international-secures-exclusive-licence-to-oesophageal-cancer-biomarkershttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/proteomics-international-laboratories-ltd-promarkerd-us-reimbursement-price-aus-regulatory-decision-marketscreenerhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/early-oesophageal-cancer-diagnosis-now-closer-for-at-risk-mirage-newshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-reports-positive-results-for-promarkereso-oesophageal-cancer-test-medical-device-networkhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-uwa-join-forces-on-new-diagnostic-test-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/proteomics-bags-chinese-patent-for-innovative-muscle-stress-test-the-agehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/fda-advises-regulatory-pathway-for-promarkerd-in-ushttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/proteomics-international-attends-anzsms-2011https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-15https://www.proteomics.com.au/news-mediahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2096.pngFrame96Frame962025-08-04https://www.proteomics.com.au/presentations/promarkerd-at-edec-2021https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/promarkereso-associate-professor-daniela-molenahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284025.jpgFrame1171284025Frame1171284025https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEso2025-10-16https://www.proteomics.com.au/presentations/proteomics-and-bioinformatics-conference-2011-hyderabad-indiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/news-media/proteomics-secures-major-pharmacokinetic-testing-contracthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/proactive-investorhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/lorne-proteomics-conference-2011-ab-workshophttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/news-media/proteomics-international-launches-new-ipohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/proteomics-international-inks-israeli-distribution-deal-for-diabetic-kidney-disease-immunoassay-360dxhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/the-future-of-endometriosis-care-phoenix-sound-by-kel-myershttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/promarkereso-homehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Hero-Banner%201.webpHeroBanner1HeroBanner1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/save_lives.svgsavelivessaveliveshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/software.svgsoftwaresoftwarehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/prescribe.svgprescribeprescribehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/sample.svgsamplesamplehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/predict.svgpredictpredicthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/plan.svgplanplanhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/analysis.svganalysisanalysishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEsohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom12026-03-17https://www.proteomics.com.au/presentations/proteomics-international-invited-to-attend-the-6th-china-international-medical-expohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/publications/examination-of-the-temporal-variation-of-peptide-content-in-decomposition-fluid-under-controlled-conditions-using-pigs-as-human-substituteshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/the-market-herald-proteomics-asxpiq-validates-prognostic-diabetes-kidney-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/blood-test-to-rule-out-esophageal-cancer-medicalxpresshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/news-media/bloomberghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/publications/comprehensive-mass-spectrometry-based-biomarker-discovery-and-validation-platform-as-applied-to-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/promarkerd-manufacturing-tech-transfer-completed-successful-production-of-components-for-over-50000-testshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/proteomics-international-laboratories-asxpiq-shows-diabetes-drug-improves-promarkerd-risk-scores-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/clinical-utility-study-demonstrates-promarkerd-test-benefitshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/endometriosis-diagnostic-promarkerendo-channel-7-news-perth-4pm-6pmhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-nails-avance-testing-contract-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/presentations/rd-pharma-partnering-world-asia-2010-singaporehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-09-24https://www.proteomics.com.au/news-media/proteomics-to-receive-928k-from-sale-of-shareholding-in-cprhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/promarkerd-kit-version-complete-commercial-release-imminenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/promarkereso-newshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEsohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-10-13https://www.proteomics.com.au/presentations/proteomics-international-attends-anzsms-2011https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/presentations/16th-human-proteome-organisation-world-congresshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-strengthens-board-and-business-development-teamhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/newsletters/april-newsletter-2019https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/endometriosis-awareness-month-what-women-need-to-watch-out-for-the-carouselhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/presentations/proteomics-international-showcased-promarker-platform-at-hupo-2019https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/pepcon-2010-beijing-chinahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-09https://www.proteomics.com.au/news-media/proteomics-streaks-ahead-with-simple-test-for-injured-racehorses-the-sydney-morning-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-07-31https://www.proteomics.com.au/news-media/early-diagnosis-a-step-closer-for-those-at-risk-of-oesophageal-cancer-biotechdispatchhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/publications/sample-identification-methodhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/world-first-predictive-test-for-diabetic-kidney-disease-could-save-384-billion-over-10-yearshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/proteomics-international-lists-on-asxhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/proteomics-international-signs-binding-letter-of-intent-with-sonic-healthcare-usa-to-take-promarkerd-into-the-us-markethttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/proteomics-showcased-promarkerd-at-bio-conventionhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/proteomics-receives-928k-from-sale-of-shareholding-in-cprhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/proteomics-international-expands-study-with-us-big-pharmahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/diabetic-kidney-disease-diagnostic-test-data-publishedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/investor-presentationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-international-sonic-healthcare-usa-sign-exclusive-licence-agreementhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/qualityhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12026-03-09https://www.proteomics.com.au/publications/clinical-performance-of-the-promarkereso-blood-test-for-diagnosing-early-stage-esophageal-adenocarcinoma-and-barretts-esophagus-with-high-grade-dysplasiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/newsletters/april-newsletter-2020https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/chile-deal-opens-wider-american-markets-for-proteomics-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-international-engages-abcam-to-manufacture-promarkerd-reagents-proactive-investorshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/asx-health-stocks-proteomics-soars-13pc-after-us-sets-price-for-promarkerd-the-daily-telegraphhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/ground-breaking-predictive-test-for-diagnosis-of-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/shares-in-value-interview-with-asx-piq-managing-directorhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-wins-major-analytical-services-contracthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/qimr-berghofer-licenses-esophageal-cancer-blood-biomarkers-to-proteomics-international-precision-oncology-newshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/presentations/american-diabetes-association-77th-scientific-sessionshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/promarkerd-test-kit-production-deal-signedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/presented-promarkerd-clinical-validation-results-with-us-big-pharmahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/proteomics-international-at-asia-biotech-invest-21-28-march-2017https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/proteomics-international-inks-deal-with-eurobio-scientific-for-french-distribution-of-kidney-test-360dxhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-29https://www.proteomics.com.au/news-media/biospectrum-asiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/newsletters/the-level-of-thiol-oxidised-plasma-albumin-is-elevated-following-a-race-in-australian-thoroughbred-horseshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/news-media/breakthrough-in-fight-against-chemically-resistant-dieback-curtin-universityhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/publications/a-comparative-study-of-the-accuracy-of-several-de-novo-sequencing-software-packages-for-datasets-derived-by-matrix-assisted-laser-desorption/ionisat-1755588990750https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/lorne-proteomics-conference-2012https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/business-developmenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20159%20(2)-1.webpFrame15921Frame159212025-11-04https://www.proteomics.com.au/news-media/proteomics-studies-back-promarkerd-for-kidney-disease-biotech-dailyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/australian-research-leads-to-groundbreaking-endometriosis-blood-test-gold-coast-magazinehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-investigates-biomarkers-for-early-detection-blood-test-for-mesotheliomahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-13https://www.proteomics.com.au/presentations/india-trade-visit-mumbai-eventhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/clinical-advisory-board-expanded-to-support-promarkerd-usa-and-global-rollouthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/newsletters/february-newsletter-2025https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-15https://www.proteomics.com.au/news-media/merck-millipore-and-proteomics-international-announce-collaborationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/business-news-asia-promarkerd-diagnostic-test-leader-officially-launchedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/international-proteomics-conference-kuala-lumpurhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-promarkerd-test-enters-the-lucrative-us-market-the-sentimenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/presentations/proteomics-international-attends-trade-shows-at-next-generation-diagnostics-summit-washington-2013https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/news-media/proteomics-international-extends-share-offerhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/proteomics-seals-exclusive-deal-for-kidney-test-in-us-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerD2025-09-29https://www.proteomics.com.au/about-ushttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%202.pngRectangle2Rectangle2https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Line%2014.pngLine14Line14https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Unrestricted%20Images/_BCC0234%20-%20Copy.jpegBCC0234CopyBCC0234Copyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/_BCC0493.webpBCC0493BCC0493https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/_BCC0517.webpBCC0517BCC0517https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/_BCC0078.jpegBCC0078BCC0078https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%203.pngRectangle3Rectangle32025-10-17https://www.proteomics.com.au/presentations/proteomics-international-attends-bioasia-india-2013https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/news-media/a-futuristic-biomarker-blood-test-could-confirm-endometriosis-diagnosis-without-surgeryhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-13https://www.proteomics.com.au/news-media/proteomics-eyes-medicare-for-rebate-inclusion-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/newsletters/december-newsletter-2015https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/us/terms-of-usehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/undefined.pngundefinedundefinedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12026-03-20https://www.proteomics.com.au/news-media/proteomics-international-interviewed-for-australian-government-rd-tax-incentive-podcasthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/precision-diagnostics-facility-receives-2m-funding-boosthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/presentations/investor-presentation-jefferies-medtech-biotech-summithttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/biotech-dailyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/bio-2010-chicago-usahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/newsletters/october-newsletter-2019https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/hupo-2010-sydney-australiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-15https://www.proteomics.com.au/presentations/australian-diabetes-society/australian-diabetes-educators-association-annual-scientific-meetinghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/newsletters/january-newsletter-2020https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-international-to-collaborate-with-university-of-melbourne-and-royal-womens-hospital-to-develop-a-test-for-endometriosis-proactive-investorshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/newsletters/april-newsletter-2018https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/proteomics-engages-growth-medics-to-expand-promarkerd-test-reach-in-eu-medical-device-networkhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-29https://www.proteomics.com.au/news-media/proteomics-international-receives-rd-tax-incentivehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/promarkerd-distribution-network-expands-to-britain-yahoo-financehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/proteomics-international-awarded-funding-to-support-diabetic-kidney-disease-test-development-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/publications/a-comprehensive-draft-genome-sequence-for-lupin-lupinus-angustifolius-an-emerging-health-food-insights-into-plant-microbe-interactions-and-legume-evolutionhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/lorne-proteomics-conference-2010-ab-workshophttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-15https://www.proteomics.com.au/news-media/thepharmaletter-proteomics-buys-stake-in-cpr-pharmahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-6m-cap-raising-lures-uk-institutions-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/newsletters/winter-newsletter-2015https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/promarkerd-updatehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-receives-1.1-million-in-rd-tax-incentivehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/intervention-needed-to-stop-kidney-disease-overwhelming-nhs-kidney-research-uk-says-evening-standardhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-29https://www.proteomics.com.au/presentations/promarkerd-showcased-at-asn-kidney-week-2020-reimaginedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-international-asxpiq-to-raise-6m-for-high-tech-blood-test-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/presentations/professor-tim-davis-on-promarkerdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/promarkerd-ms.-davida-krugerhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-1.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-18https://www.proteomics.com.au/news-media/proteomics-tech-emerges-as-early-dieback-diagnosis-keyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-international-to-present-at-the-emerging-asx-gems-conferencehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/publications/plasma-membrane-receptor-like-kinases-and-transporters-are-associated-with-24-d-resistance-in-wild-radishhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/ddnewshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/proteomics-wins-wa-export-award-2018https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/promarkerd-newshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-1%20(1).webpimage11image11https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-5.pngimage5image5https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-4%20(1).pngimage41image41https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-3%20(1).webpimage31image31https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-2%20(1).pngimage21image21https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-251-1.pngimage2511image2511https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%20(1)-1.webpimage11image11https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-252-1.pngimage2521image25212025-10-03https://www.proteomics.com.au/proteomics-nears-agreement-to-sell-kidney-disease-test-in-usa-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerD2025-09-29https://www.proteomics.com.au/news-media/proteomics-international-laboratories-ltd-asxpiq-new-oesophageal-cancer-test-presented-at-global-conference-menafnhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/publications/analysis-by-proteomics-reveals-unique-circulatory-proteins-in-idiopathic-pulmonary-fibrosishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/new-endometriosis-test-could-diagnose-without-surgery-marie-claire-australiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-asxpiq-awarded-100000-project-grant-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/publications/a-clinical-validation-of-a-diagnostic-test-for-esophageal-adenocarcinoma-based-on-a-novel-serum-glycoprotein-biomarker-panel-promarkeresohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/presentations/proteomics-international-at-perth-protein-group-inaugural-agmhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/managing-director-dr-richard-lipscombe-presents-promarkerd-in-the-usahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/news-media/the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/newsletters/july-newsletter-2021https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/new-blood-test-could-measure-muscle-damage-in-elite-athletes-study-suggests-deccan-herald-indiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/reutershttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/patient-storyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/iStock-1432338987.jpgiStock1432338987iStock14323389872025-10-16https://www.proteomics.com.au/news-media/proteomics-to-expand-operations-in-indian-markethttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-13https://www.proteomics.com.au/news-media/proteomics-testing-pinpoints-future-kidney-disease-risks-the-agehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-reveals-new-blood-test-to-identify-endometriosis-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/presentations/agm-presentation-2021https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-receives-rd-tax-incentive-aumanufacturinghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/proteomics-international-secures-significant-biosimilars-contracthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/promarkereso-clinical-studieshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Licensed%20Images/OKMD%20purchased/Advisory%20Board%201200px.jpegAdvisoryBoard1200pxAdvisoryBoard1200pxhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEsohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/clinical-studies-new-1.pngclinicalstudiesnew1clinicalstudiesnew1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/multi_center.pngmulticentermulticenterhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Licensed%20Images/OKMD%20purchased/iStock-1046693950.jpgiStock1046693950iStock10466939502025-10-24https://www.proteomics.com.au/newsletters/limiting-the-hydrolysis-and-oxidation-of-maleimidepeptide-adducts-improves-detection-of-protein-thiol-oxidationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/newsletters/summer-newsletter-2015https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/promarkerd-predictive-diagnostic-test-to-launch-in-q1-2018https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-international-awarded-400000-to-support-manufacturing-capability-in-australiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/analytical-serviceshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Analytical%20Services/Social%20Post%20Images/PK%20tile%20image%20CanvaPro%20create%20250624SS.pngPKtileimageCanvaProcreate250624SSPKtileimageCanvaProcreate250624SShttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Analytical%20Services/Social%20Post%20Images/BS%20tile%20image%20CanvaPro%20to%20Paint%20250624SS.pngBStileimageCanvaProtoPaint250624SSBStileimageCanvaProtoPaint250624SShttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Analytical%20Services/Social%20Post%20Images/Project%20consultation%20tile%20image%20CanvaPro%20create%20250624SS.pngProjectconsultationtileimageCanvaProcreate250624SSProjectconsultationtileimageCanvaProcreate250624SShttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Analytical%20Services/Social%20Post%20Images/PT%20tile%20image%20CanvaPro%20to%20Paint%20250624SS.pngPTtileimageCanvaProtoPaint250624SSPTtileimageCanvaProtoPaint250624SShttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%204%20(1).pngRectangle41Rectangle41https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Analytical%20Services/Social%20Post%20Images/Order%20tile%20image%20CanvaPro%20Create%20250624SS.pngOrdertileimageCanvaProCreate250624SSOrdertileimageCanvaProCreate250624SShttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/WAP%20Brochure%20(1).pngWAPBrochure1WAPBrochure1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Analytical%20Services/Social%20Post%20Images/T&C%20tile%20image%20CanvaPro%20Create%20250624SS%20Pro.pngTCtileimageCanvaProCreate250624SSProTCtileimageCanvaProCreate250624SSProhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Analytical%20Services/Social%20Post%20Images/Biomarker%20tile%20image%20for%20AS%20main%20page%20CanvaPro%20Creation%20250624SS.pngBiomarkertileimageforASmainpageCanvaProCreation250624SSBiomarkertileimageforASmainpageCanvaProCreation250624SShttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Analytical%20Services/Social%20Post%20Images/Downloads%20tile%20image%20CanvaPro%20250624SS.pngDownloadstileimageCanvaPro250624SSDownloadstileimageCanvaPro250624SS2025-10-16https://www.proteomics.com.au/presentations/investor-presentation-euroz-hartleys-institutional-conference-2022https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/promarkerd-at-easdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/small-caps-proteomics-commences-european-campaign-to-advance-promarkerd-diabetic-kidney-disease-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/promarkerd-homehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/treatment-1.svgtreatment1treatment1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/sample.svgsamplesamplehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/software.svgsoftwaresoftwarehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/identification-1.svgidentification1identification1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/doctors.svgdoctorsdoctorshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/test_banner-1%20(1)%20(1)%201%20(1)-Photoroom.pngtestbanner11111Photoroomtestbanner11111Photoroomhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/plan.svgplanplanhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/analysis.svganalysisanalysishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerD2026-03-17https://www.proteomics.com.au/presentations/australasian-diabetes-congress-panel-discussionhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/investor-presentation-broker-meets-biotechhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-international-wins-wa-exporter-of-the-year-awardhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/proteomics-international-presents-promarkerd-at-idf-2015-vancouver-world-diabetes-congresshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/presentations/investor-presentation-bell-potter-healthcare-conferencehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-12-16https://www.proteomics.com.au/news-media/proteomics-gets-green-light-to-continue-diagnostic-mission-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/biospace-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/the-australian-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/terms-of-usehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12026-03-20https://www.proteomics.com.au/newsletters/january-newsletter-2018https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/newsletters/july-newsletter-2016https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/publications/a-robust-multiplex-immunoafnity-mass-spectrometry-assay-promarkerd-for-clinical-prediction-of-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/unique-panel-of-biomarkers-identified-for-oesophageal-cancerhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/coming-soon-a-blood-test-that-diagnoses-endometriosis-health-centralhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/diabetic-kidney-disease-patent-granted-in-russiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/middle-east-is-next-market-for-promarkerd-immunoassay-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/newsletters/april-newsletter-2016https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/promarkerd-development-advances-in-chinahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-13https://www.proteomics.com.au/presentations/investor-eventhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/bell-potter-healthcare-conference-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/promarkerd-test-scores-show-treatment-with-canagliflozin-can-lessen-risk-of-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/mtp-connect-proteomics-international-signs-deal-with-prismhealthdx-to-launch-promarkerd-predictive-test-for-diabetic-kidney-disease-in-usahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-wins-biotech-testing-contract-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/presentations/promarkerd-at-era-edtahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/blood-test-for-kidney-decline-in-type-1-diabetes-medical-forumhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/sample-deliveryhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/GoLocation.svgGoLocationGoLocationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/67d24cd076ee8ae0177e2d628833a257c880b106.webp67d24cd076ee8ae0177e2d628833a257c880b10667d24cd076ee8ae0177e2d628833a257c880b1062025-10-17https://www.proteomics.com.au/news-media/1-million-funding-to-develop-diabetic-kidney-disease-biomarkers-into-a-companion-diagnostic-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/pharmacokinetic-testinghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20159-1.pngFrame1591Frame15912025-10-16https://www.proteomics.com.au/news-media/promarker-pipeline-endometriosis-update-diagnostic-readout-positive-study-expandedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/publications/the-impact-of-environmental-factors-on-the-production-of-peptides-in-mammalian-decomposition-fluidhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/chile-deal-opens-wider-american-markets-for-proteomics-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-29https://www.proteomics.com.au/news-media/proteomics-international-featured-in-ausindustry-business-news-monthlyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/presentations/corporate-presentation-proactives-ceo-spotlight-investor-sessions-melbourne-sydneyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/mediahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Screenshot%202025-09-25%20at%204.19.11%20PM.pngScreenshot20250925at41911PMScreenshot20250925at41911PMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Screenshot%202025-09-25%20at%204.22.12%20PM.pngScreenshot20250925at42212PMScreenshot20250925at42212PMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Presentation.pngPresentationPresentationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20292%20(5).pngFrame2925Frame2925https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Screenshot%202025-09-25%20at%204.10.37%20PM.pngScreenshot20250925at41037PMScreenshot20250925at41037PMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Screenshot%202025-09-25%20at%204.12.22%20PM.pngScreenshot20250925at41222PMScreenshot20250925at41222PMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20292%20(3).pngFrame2923Frame2923https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Media%20Page%20Thumbnail.pngMediaPageThumbnailMediaPageThumbnailhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20292%20(6).pngFrame2926Frame2926https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Media%20Page%20Thumbnails.pngMediaPageThumbnailsMediaPageThumbnailshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Screenshot%202025-09-25%20at%204.20.52%20PM.pngScreenshot20250925at42052PMScreenshot20250925at42052PMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Media%20Page%20Thumbnail-1.pngMediaPageThumbnail1MediaPageThumbnail1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Screenshot%202025-09-25%20at%204.05.53%20PM.pngScreenshot20250925at40553PMScreenshot20250925at40553PMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Screenshot%202025-09-25%20at%204.08.45%20PM.pngScreenshot20250925at40845PMScreenshot20250925at40845PMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20292%20(4).pngFrame2924Frame29242026-03-29https://www.proteomics.com.au/presentations/investor-presentation-euroz-hartleys-institutional-conference-2021https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-and-dimerix-partner-to-improve-the-treatment-of-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/privacy-policyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12026-03-09https://www.proteomics.com.au/promarkerd-dr-michael-h.-shanikhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-2.pngimage2image22025-09-18https://www.proteomics.com.au/news-media/proteomics-international-appoints-new-directorhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/4th-international-congress-on-prediabetes-the-metabolic-syndrome-2011-madrid-spainhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/promarkerd-publicationshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-252%20(1).pngimage2521image2521https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-264.pngimage264image264https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/clinical-studies%20(1).pngclinicalstudies1clinicalstudies1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/publication_banner-1%201.pngpublicationbanner11publicationbanner11https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/svgviewer-output.svgsvgvieweroutputsvgvieweroutputhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-265.pngimage265image265https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-263-Picsart-AiImageEnhancer.pngimage263PicsartAiImageEnhancerimage263PicsartAiImageEnhancer2025-10-16https://www.proteomics.com.au/news-media/endometriosis-blood-test-abc-radiohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/promarkerd-test-ready-for-launch-in-europehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/fingerprick-blood-test-detects-muscle-damage-and-tracks-recovery-in-elite-athletes-medical-xpresshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/medianet-proteomics-international-signs-deal-with-prismhealthdx-to-launch-promarkerd-predictive-test-for-diabetic-kidney-disease-in-usahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/biospectrum-asia-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/publications/comparative-sub-cellular-proteome-analyses-reveals-metabolic-differentiation-and-production-of-effector-like-molecules-in-the-dieback-phytopathogen-1755500427143https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-international-inks-italian-distribution-deal-for-diabetic-kidney-disease-immunoassay-360dxhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/the-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/6pr-audio-proteomics-predicting-a-disease-before-you-get-it-now-thats-novelhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/biotech-daily-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/worlds-first-blood-test-for-endometriosis-step-closer-following-trial-success-science-alert-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/technical-supporthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/iStock-1387090964.webpiStock1387090964iStock1387090964https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-11-04https://www.proteomics.com.au/news-media/proteomics-international-raises-6m-in-heavily-oversubscribed-placementhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/proteomics-seals-kidney-disease-test-supply-deal-in-france-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-29https://www.proteomics.com.au/news-media/american-doctors-give-tick-to-proteomics-kidney-test-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/bangalore-india-bio-2010https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/news-media/us-patent-for-identifying-drugs-for-abnormal-kidney-functionhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/diabetic-kidney-disease-test-enters-europe-export-awardhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/qeii-bioinnovation-showcase-and-partneringhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/us-promarkerd-patent-expanded-to-all-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/proteomics-international-wins-wa-exporter-of-the-year-awardhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/news-media/proteomics-partnered-consortium-to-receive-2-millionhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/proteomics-boosts-european-presence-with-diabetes-device-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-09-29https://www.proteomics.com.au/publications/semi-automated-lectin-magnetic-bead-array-lemba-for-translational-serum-glycoprotein-biomarker-discovery-and-validationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/publications/promarkerd-versus-standard-of-care-biochemical-measures-for-assessing-future-renal-function-decline-in-type-2-diabeteshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/contacthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20333.pngFrame333Frame333https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20335%20(2).pngFrame3352Frame3352https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/MdOutlineCall.svgMdOutlineCallMdOutlineCallhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Line%2014.pngLine14Line14https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Analytical%20Services/Submit-your-service-enquiry.jpgSubmityourserviceenquirySubmityourserviceenquiryhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20331-1.pngFrame3311Frame3311https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20334%20(1).pngFrame3341Frame3341https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/GoLocation.svgGoLocationGoLocationhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20336%20(1).pngFrame3361Frame3361https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20332%20(1).pngFrame3321Frame33212026-01-16https://www.proteomics.com.au/news-media/proteomics-nails-near-perfect-results-for-endometriosis-blood-test-the-sydney-morning-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/publications/a-clinical-validation-of-a-diagnostic-test-for-esophageal-adenocarcinoma-based-on-a-novel-serum-glycoprotein-biomarker-panel-promarkereso-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-16https://www.proteomics.com.au/news-media/proteomics-international-to-commercialise-dkd-test-in-chinahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/publications/the-level-of-thiol-oxidised-plasma-albumin-is-elevated-following-a-race-in-australian-thoroughbred-horseshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-international-biomarker-study-moves-closer-to-a-cdx-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/diabetes.co.ukhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/newsletters/april-newsletter-2022https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/smallcaps-proteomics-international-and-dimerix-join-forces-to-combat-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-international-laboratories-ltd-asxpiq-managing-director-interviewed-about-the-promarker-suite-of-diagnostic-tests-abn-newswirehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/promarkereso-advisory-boardhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/team_banner-1%201.webpteambanner11teambanner11https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-252%20(1).pngimage2521image2521https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284025.jpgFrame1171284025Frame1171284025https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/clinical-studies%20(1).pngclinicalstudies1clinicalstudies1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284027.jpgFrame1171284027Frame1171284027https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284024.jpgFrame1171284024Frame1171284024https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284023.jpgFrame1171284023Frame1171284023https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEsohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284021-1024x536.jpgFrame11712840211024x536Frame11712840211024x536https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284022.jpgFrame1171284022Frame1171284022https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284026.jpgFrame1171284026Frame11712840262025-10-28https://www.proteomics.com.au/news-media/blood-test-or-crystal-ball-looking-into-the-future-of-our-health-the-sentimenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/promarkereso-professor-robert-odzehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEsohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284026.jpgFrame1171284026Frame11712840262025-10-16https://www.proteomics.com.au/news-media/promarkerd-distribution-network-expands-to-britainhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/presentations/managing-director-dr-richard-lipscombe-presents-at-the-11th-australian-peptide-conference-2015https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/news-media/proteomics-international-laboratories-asxpiq-completes-promarkerd-manufacturing-tech-transfer-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/the-silent-killer-prevention-is-the-next-cure-phase-iii-podcasthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-international-laboratories-asxpiq-receives-1.2-million-rd-incentive-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/proteomics-teams-with-oxford-university-for-endometriosis-study-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/360dx-proteomics-international-presents-study-data-supporting-promarkerd-kidney-disease-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/proteomics-and-linear-to-offer-end-to-end-testing-and-clinical-trialshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/intervention-needed-to-stop-kidney-disease-overwhelming-nhs-kidney-research-uk-says-evening-standardhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/european-promarkerd-patents-expanded-beyond-diabeteshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/publications/alpha-2-giardin-is-an-assemblage-a-specific-protein-of-human-infective-giardia-duodenalishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/new-proteomics-blood-test-unlocks-better-oesophageal-cancer-detection-the-agehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/wholesale-investorhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/promarkerd-shows-improved-predictive-ability-and-robustnesshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/proteomics-international-to-present-at-the-emerging-asx-gems-conferencehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/study-boosts-diagnostic-potential-for-proteomics-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/promarkerd-clinical-studieshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-252%20(1).pngimage2521image2521https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/multi_center.pngmulticentermulticenterhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/clinical_studies-1.webpclinicalstudies1clinicalstudies1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerDhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image-251.pngimage251image251https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom12025-10-16https://www.proteomics.com.au/news-media/proteomics-commences-therapeutic-drug-discovery-programhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-13https://www.proteomics.com.au/news-media/cutting-edge-protein-biomarker-analysis-facility-for-western-australiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/learning-from-uks-kidney-disease-crisis-medical-forum-magazinehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-signs-promarkerd-agreement-with-us-big-pharmahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/chronic-kidney-disease-with-dr-richard-lipscombe-channel-9-news-perth-5pm-bulletinhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/promarkerd-professor-merlin-thomashttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/PromarkerD/Advisory%20Board/Merlin%20Thomas%201.pngMerlinThomas1MerlinThomas1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerD2025-10-06https://www.proteomics.com.au/newsletters/april-newsletter-2017https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/publications/deep-proteogenomics-high-throughput-gene-validation-by-multidimensional-liquid-chromatography-and-mass-spectrometry-of-proteins-from-the-fungal-whea-1755586530586https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12026-01-16https://www.proteomics.com.au/news-media/breakthrough-blood-test-for-endometriosis-study-racgphttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/presentations/biosimilars-the-synergy-between-australian-industry-and-indian-pharmaceuticalshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/news-media/proteomics-seals-kidney-disease-test-supply-deal-in-france-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/newsletters/december-newsletter-2023https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-seeks-fda-approval-for-blood-test-kit-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/promarkerd-predictive-test-results-published-diabetes-carehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-launches-promarkerdhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/publicationshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2096.pngFrame96Frame962025-08-18https://www.proteomics.com.au/presentations/the-promarkerd-test-and-how-it-workshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/publications/proteomic-analysis-revealed-that-the-oomyceticide-phosphite-exhibits-multi-modal-action-in-an-oomycete-pathosystemhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/newsletters/october-newsletter-2021https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/how-digital-health-infrastructure-and-advanced-medical-devices-will-increase-the-opportunity-for-personalised-care-medhealth-insighthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/interview-with-our-managing-directorhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/market-watchhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/careershttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/234%20Proteomics.webp234Proteomics234Proteomicshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2068%20(1)-1.webpFrame6811Frame6811https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12026-03-08https://www.proteomics.com.au/news-media/proteomics-receives-rd-tax-incentivehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/newsletters/may-newsletter-2023https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-15https://www.proteomics.com.au/nhs-facing-impossible-challenge-to-care-for-kidney-disease-patients-kidney-research-uk-warns-itvhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerD2025-09-29https://www.proteomics.com.au/news-media/the-perth-health-tech-company-batting-well-above-its-average-6pr-perth-radio-money-newshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/vast-us-market-opportunity-seen-for-proteomics-kidney-test-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/presentations/proteomics-international-is-at-ausbiotech-31st-october-to-2nd-november-2018https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/corporate-presentation-asia-biotech-investhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/news-media/endometriosis-blood-testing-makes-progress-in-neglected-field-the-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/promarkerd-patent-granted-in-hong-konghttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/newsletters/july-newsletter-2018https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/newsletters/october-newsletter-2017https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-at-ada-diabetes-conferencehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/bloomberg-proteomics-international-alliance-and-investment-in-cpr-pharmahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/investor-presentation-perth-healthcare-summithttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/promarkerd-international-validation-study-results-publishedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/business-news-asiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-atturos-partner-to-target-diagnostics-in-europehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/study-demonstrates-major-economic-health-benefit-of-promarkerd-promarkerd-reimbursement-updatehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/proteomics-boosts-kidney-test-prospects-with-board-gains-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/proteomics-international-asxpiq-to-present-new-oesophageal-cancer-test-at-global-conference-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-scores-approval-for-perth-diagnostics-lab-the-agehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-22https://www.proteomics.com.au/news-media/diabetes-treatment-lowers-promarkerd-risk-score-results-presented-at-australasian-diabetes-congresshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/proteomics-international-signs-deal-to-launch-promarkerd-test-for-diabetic-kidney-disease-in-usahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/diagnostics-rd-expanded-the-promarker-pipelinehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/export-council-of-australia-winners-of-the-31st-western-australian-industry-and-export-awards-announcedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/bioshares-biotech-summithttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/newsletters/october-newsletter-2016https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/presentations/hupo-2010-sydney-australiahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-09-24https://www.proteomics.com.au/news-media/proteomics-international-goes-publichttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/news-media/distribution-agreement-for-promarkerd-in-britain-extendedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/news-media/western-suburbs-posthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/sbs-news-diabetes-sufferers-could-soon-predict-whether-their-kidney-will-deteriorate-following-an-australian-companys-launch-of-a-diagnostic-test-in-the-us-markethttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/bell-financial-groups-grady-wulff-speaks-with-proteomics-international-laboratories-asx-piq-ceo-dr.-richard-lipscombe-about-the-companys-ground-breaki-1767959732064https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12026-01-09https://www.proteomics.com.au/news-media/promarkerd-significantly-outperforms-current-standard-of-care-tests-in-predicting-future-kidney-function-declinehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/proteomics-joins-major-health-study-to-target-lung-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/promarkerd-registration-submitted-to-the-tgahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/presentations/pepcon-2010-beijing-chinahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-09-24https://www.proteomics.com.au/news-media/proteomics-international-receives-covid-19-research-grantshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/investor-webinar-and-qa-session-3rd-october-2024https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/europe-promarkerd-patent-granted-for-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/new-company-website-and-corporate-videohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-13https://www.proteomics.com.au/news-media/small-caps-tony-locantro-whats-happening-in-the-gold-sector-and-6-biotech-stockshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/proteomics-international-signs-agreement-with-inventiv-health-clinicalhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/adverse-eventshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/s3.webps3s32025-10-17https://www.proteomics.com.au/news-media/silicon-investor-promarkerd-diagnostic-test-leader-officially-launchedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/investor-presentation-august-2020https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/proteomics-international-india-trade-visit-april-2016-expanding-operations-in-indian-biotech-sectorhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-20https://www.proteomics.com.au/presentations/bangalore-india-bio-2010https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/news-media/proteomics-signs-deal-for-distribution-of-promarkerd-in-italy-biotech-dispatchhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/request-an-analytical-services-proposalhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Line%2014.pngLine14Line14https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20162.pngFrame162Frame1622026-03-20https://www.proteomics.com.au/news-media/new-clinical-advisory-board-to-support-promarkerd-global-rollout-yahoo-finance-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/faster-easier-endometriosis-diagnosis-on-the-horizon-new-england-timeshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/presentations/bell-potter-healthcare-conferencehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-international-laboratories-asxpiq-signs-distribution-deal-for-diabetic-kidney-disease-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/presentations/investor-presentation-euroz-hartleys-healthcare-forum-1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/proteomics-showcased-promarkerd-at-bio-conventionhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/lorne-proteomics-conference-2010-ab-workshophttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-21https://www.proteomics.com.au/news-media/proteomics-secures-major-contract-nears-cash-flow-positivehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/presentations/proteomics-international-was-an-exhibitor-at-ausbiotech-2017-25th-27th-october-2017https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proteomics-international-laboratories-asxpiq-contracts-biotem-to-manufacture-test-kits-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/engineers-journal-test-to-predict-onset-of-diabetic-kidney-disease-step-closer-to-launch-across-europehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/proteomics-international-wins-wa-industry-and-export-awardhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-14https://www.proteomics.com.au/publications/immunoaffinity-mass-spectrometry-diagnostic-tests-for-multi-biomarker-assayshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/new-directors-appointed-to-company-boardhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-07https://www.proteomics.com.au/news-media/proteomics-international-laboratories-ltd-oxidx-platform-technology-secures-patent-in-japan-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/glossaryhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/_BCC0471.webpBCC0471BCC0471https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/_BCC0337.webpBCC0337BCC03372025-10-16https://www.proteomics.com.au/presentations/investor-presentation-non-deal-roadshowhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/investor-presentation-morgan-stanley-alpha-ex-100-conferencehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/presentations/proactives-ceo-spotlight-investor-briefings-melbourne-and-sydneyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/proactive-investors-australia-proteomics-international-laboratories-secures-indonesian-patent-for-its-diagnostic-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/australian-rd-tax-incentive-customer-stories-proteomics-international-saving-lives-through-new-predictive-diagnostic-testshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/good-news-of-the-week-company-nears-world-first-blood-test-for-endometriosis-itn-businesshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-01https://www.proteomics.com.au/news-media/promarkerd-ivd-successfully-developed-and-validatedhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/news-media/proteomics-international-quarterly-business-updatehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-13https://www.proteomics.com.au/news-media/asia-pacific-biotech-newshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/news-media/proteomics-signs-deal-with-patia-for-promarkerd-in-mexicohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/publications/protein-network-analysis-identifies-changes-in-the-level-of-proteins-involved-in-platelet-degranulation-proteolysis-and-cholesterol-metabolism-pathw-1755505124249https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/promarkerd-application-for-australian-medicare-benefits-schedule-listing-investor-webinarhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-06https://www.proteomics.com.au/promarkereso-professor-prasad-iyerhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEsohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame-1171284024.jpgFrame1171284024Frame1171284024https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationby2025-10-16https://www.proteomics.com.au/publications/validation-of-a-protein-biomarker-test-for-predicting-renal-decline-in-type-2-diabetes-the-fremantle-diabetes-study-phase-iihttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/publications/analysis-of-reproducibility-of-proteome-coverage-and-quantitation-using-isobaric-mass-tags-itraq-and-tmthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/bioworld-proteomics-rolls-out-blood-based-diagnostic-to-predict-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/proteomics-inks-kidney-disease-test-deal-in-mid-east-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/proteomics-international-asxpiq-pursues-fda-approval-for-promarkerd-the-market-heraldhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/news-media/what-is-the-new-blood-test-for-endometriosis-mydrhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/diagnostics-update-the-promarker-pipelinehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-12https://www.proteomics.com.au/publications/expression-of-cardiac-a-actin-spares-extraocular-muscles-in-skeletal-muscle-a-actin-diseases-quantification-of-striated-a-actins-by-mrm-mass-spectrometryhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/publications/analytical-and-clinical-performance-of-a-novel-immunoassay-based-test-system-to-predict-diabetic-kidney-diseasehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/healthcare-providershttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/iStock-949054764-1%201.webpiStock94905476411iStock94905476411https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/healthcare_provider_bottom-1.webphealthcareproviderbottom1healthcareproviderbottom1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Screenshot%202025-10-07%20at%204.30.09%20PM.pngScreenshot20251007at43009PMScreenshot20251007at43009PMhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/IJ-man-for-Eso-used-in-brochure-1-1.webpIJmanforEsousedinbrochure11IJmanforEsousedinbrochure11https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AEEso.pngPromarkerEsoPromarkerEsohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/clinical_utility-1.pngclinicalutility1clinicalutility12025-12-13https://www.proteomics.com.au/publications/evidence-for-alterations-in-protein-expression-and-function-after-5-minutes-exposure-of-ventricular-myocytes-to-h2o2https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/promarkerd-hits-latin-americahttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-13https://www.proteomics.com.au/board-of-directorshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%201%20(13).pngRectangle113Rectangle113https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Corporate/Staff%20Headshots/296db9bc6f8a0bbc642aecdd4f281d52006106391bddb7f246e31f4004c2115b%20(1).webp296db9bc6f8a0bbc642aecdd4f281d52006106391bddb7f246e31f4004c2115b1296db9bc6f8a0bbc642aecdd4f281d52006106391bddb7f246e31f4004c2115b1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Corporate/Staff%20Headshots/Profile%20photo.jpgProfilephotoProfilephotohttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%2096.pngFrame96Frame96https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%201%20(10).pngRectangle110Rectangle110https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/2025.01.05_ABrinkworth_headshot.jpg20250105ABrinkworthheadshot20250105ABrinkworthheadshothttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%201%20(11).pngRectangle111Rectangle111https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Rectangle%201%20(9).pngRectangle19Rectangle192026-01-27https://www.proteomics.com.au/newsletters/july-newsletter-2017https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/downloadshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Line%2014.pngLine14Line14https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Frame%20163.pngFrame163Frame1632026-01-16https://www.proteomics.com.au/proteomics-promarkerd-test-enters-the-lucrative-us-market-the-sentimenthttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Logos_Brand/Proteomics%20company/innovation_by.pnginnovationbyinnovationbyhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/Imported%20sitepage%20images/Promarker%C2%AED.pngPromarkerDPromarkerD2025-09-29https://www.proteomics.com.au/news-media/the-west-australian-major-clinical-study-validates-proteomics-kidney-testhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-08https://www.proteomics.com.au/publications/an-external-quality-assurance-trial-to-assess-mass-spectrometry-protein-testing-facilities-for-identifying-multiple-human-peptideshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-18https://www.proteomics.com.au/news-media/proteomics-boosts-european-presence-with-diabetes-device-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/screening-for-oesophageal-cancer-promarkereso-healthy-living-2gbhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/news-media/proteomics-international-to-patent-biomarkers-for-diagnosis-of-endometriosishttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-11https://www.proteomics.com.au/presentations/proteomics-international-india-trade-visit-4th-8th-september-2017https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-19https://www.proteomics.com.au/news-media/rd-pharma-partnering-world-asia-2010-singaporehttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-10-09https://www.proteomics.com.au/news-media/proteomics-blood-test-primed-for-cancer-fight-the-west-australianhttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image12025-08-04https://www.proteomics.com.au/temp_investor_relationshttps://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/image%201.pngimage1image1https://39836784.fs1.hubspotusercontent-na1.net/hubfs/39836784/Content%20Management/Images/234%20Proteomics.webp234Proteomics234Proteomics2025-11-11